AG˹ٷ

STOCK TITAN

[Form 4] GMS Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Arteris, Inc. (AIP) � Form 144 filing. An affiliated holder, identified via the Viana Family Trust, has filed notice to sell 6,909 common shares through Morgan Stanley Smith Barney on or after 08 Aug 2025. Estimated aggregate market value of the proposed sale is $65,290.05, implying an average price of roughly $9.45 per share. The amount represents only about 0.02 % of the 41,977,728 shares outstanding, signalling a modest transaction size relative to the float.

The shares derive from stock options exercised on 28 Jan 2021 and will be executed on NASDAQ. During the last three months the same trust has already sold 19,287 shares for gross proceeds of $147,593.77 under a Rule 10b5-1 plan. The filer affirms no undisclosed material adverse information.

Arteris, Inc. (AIP) � Deposito del Modulo 144. Un detentore affiliato, identificato tramite il Viana Family Trust, ha presentato notifica per la vendita di 6.909 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 08 agosto 2025. Il valore di mercato stimato dell'operazione proposta è di 65.290,05 $, con un prezzo medio di circa 9,45 $ per azione. La quantità rappresenta solo circa lo 0,02% delle 41.977.728 azioni in circolazione, indicando una dimensione modesta della transazione rispetto al flottante.

Le azioni derivano da opzioni azionarie esercitate il 28 gennaio 2021 e saranno negoziate sul NASDAQ. Negli ultimi tre mesi lo stesso trust ha già venduto 19.287 azioni per un ricavo lordo di 147.593,77 $ nell'ambito di un piano Rule 10b5-1. Il dichiarante conferma l'assenza di informazioni materiali negative non divulgate.

Arteris, Inc. (AIP) � Presentación del Formulario 144. Un titular afiliado, identificado a través del Viana Family Trust, ha presentado aviso para vender 6,909 acciones comunes mediante Morgan Stanley Smith Barney a partir del 08 de agosto de 2025. El valor de mercado estimado de la venta propuesta es de $65,290.05, implicando un precio promedio de aproximadamente $9.45 por acción. La cantidad representa solo alrededor del 0.02% de las 41,977,728 acciones en circulación, señalando un tamaño modesto de la transacción en relación con el float.

Las acciones provienen de opciones sobre acciones ejercidas el 28 de enero de 2021 y se ejecutarán en NASDAQ. Durante los últimos tres meses, el mismo fideicomiso ya ha vendido 19,287 acciones por ingresos brutos de $147,593.77 bajo un plan Rule 10b5-1. El declarante afirma no poseer información adversa material no divulgada.

Arteris, Inc. (AIP) � Form 144 제출. Viana Family Trust� 통해 식별� 계열 보유자가 6,909 보통�� Morgan Stanley Smith Barney� 통해 2025� 8� 8� 이후� 매각� 예정임을 신고했습니다. 제안� 매각� 추정 � 시장 가치는 $65,290.05이며, 주당 � $9.45� 평균 가격을 의미합니�. 이는 유통 주식 � 41,977,728� � � 0.02%� 해당하는 양으�, 유통 주식 대� 거래 규모가 작음� 나타냅니�.

해당 주식은 2021� 1� 28�� 행사� 스톡 옵션에서 비롯되었으며 NASDAQ에서 거래� 예정입니�. 지� 3개월 동안 동일� 신탁은 Rule 10b5-1 계획� 따라 이미 19,287�� 매도하여 � 수익 $147,593.77� 기록했습니다. 제출자는 공개되지 않은 중대� 부정적 정보가 없음� 확인했습니다.

Arteris, Inc. (AIP) � Dépôt du formulaire 144. Un détenteur affilié, identifié via le Viana Family Trust, a déposé un avis pour vendre 6 909 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney à partir du 8 août 2025. La valeur marchande estimée de la vente proposée est de 65 290,05 $, ce qui implique un prix moyen d'environ 9,45 $ par action. Le montant représente seulement environ 0,02 % des 41 977 728 actions en circulation, indiquant une taille de transaction modeste par rapport au flottant.

Les actions proviennent d'options sur actions exercées le 28 janvier 2021 et seront négociées sur le NASDAQ. Au cours des trois derniers mois, le même trust a déjà vendu 19 287 actions pour un produit brut de 147 593,77 $ dans le cadre d'un plan Rule 10b5-1. Le déposant affirme qu'aucune information négative importante non divulguée n'est présente.

Arteris, Inc. (AIP) � Einreichung des Formulars 144. Ein verbundener Inhaber, identifiziert über den Viana Family Trust, hat die Absicht gemeldet, 6.909 Stammaktien über Morgan Stanley Smith Barney ab dem 08. August 2025 zu verkaufen. Der geschätzte Gesamtmarktwert des geplanten Verkaufs beträgt 65.290,05 $, was einem durchschnittlichen Preis von etwa 9,45 $ pro Aktie entspricht. Die Menge macht nur etwa 0,02 % der 41.977.728 ausstehenden Aktien aus und signalisiert eine überschaubare Transaktionsgröße im Verhältnis zum Streubesitz.

Die Aktien stammen von am 28. Januar 2021 ausgeübten Aktienoptionen und werden an der NASDAQ gehandelt. In den letzten drei Monaten hat derselbe Trust bereits 19.287 Aktien für Bruttoerlöse von 147.593,77 $ im Rahmen eines Rule 10b5-1 Plans verkauft. Der Meldende bestätigt das Fehlen nicht offengelegter wesentlicher negativer Informationen.

Positive
  • Minimal dilution risk: 6,909 shares equal only 0.02 % of outstanding, posing no material supply pressure.
  • Pre-arranged 10b5-1 plan limits the likelihood of information asymmetry behind the sale.
Negative
  • Continued insider selling: Trust has sold 19,287 shares in the prior three months, which could dampen investor sentiment if the pattern persists.

Insights

TL;DR � Very small insider sale; minimal dilution, slight supply overhang.

The 6.9k-share sale equals ~0.02 % of AIP’s outstanding stock, suggesting negligible impact on liquidity or control. Combined with prior 19.3k shares sold this quarter, the trust’s total disposals remain immaterial in dollar and percentage terms. Because the sale is pre-arranged via 10b5-1, it likely reflects diversification rather than a shift in insider outlook. Market reaction should be limited, yet frequent insider selling can weigh marginally on sentiment.

TL;DR � Filing is routine, not materially impactful for valuation.

With sub-$0.1 m value, the proposed sale is far below thresholds that typically influence supply-demand dynamics for AIP’s ~$350 m market cap. No new operational data or guidance accompanies the notice, so fundamental risk profile is unchanged. I classify the disclosure as not impactful; however, ongoing insider distribution trends deserve monitoring if volumes escalate.

Arteris, Inc. (AIP) � Deposito del Modulo 144. Un detentore affiliato, identificato tramite il Viana Family Trust, ha presentato notifica per la vendita di 6.909 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 08 agosto 2025. Il valore di mercato stimato dell'operazione proposta è di 65.290,05 $, con un prezzo medio di circa 9,45 $ per azione. La quantità rappresenta solo circa lo 0,02% delle 41.977.728 azioni in circolazione, indicando una dimensione modesta della transazione rispetto al flottante.

Le azioni derivano da opzioni azionarie esercitate il 28 gennaio 2021 e saranno negoziate sul NASDAQ. Negli ultimi tre mesi lo stesso trust ha già venduto 19.287 azioni per un ricavo lordo di 147.593,77 $ nell'ambito di un piano Rule 10b5-1. Il dichiarante conferma l'assenza di informazioni materiali negative non divulgate.

Arteris, Inc. (AIP) � Presentación del Formulario 144. Un titular afiliado, identificado a través del Viana Family Trust, ha presentado aviso para vender 6,909 acciones comunes mediante Morgan Stanley Smith Barney a partir del 08 de agosto de 2025. El valor de mercado estimado de la venta propuesta es de $65,290.05, implicando un precio promedio de aproximadamente $9.45 por acción. La cantidad representa solo alrededor del 0.02% de las 41,977,728 acciones en circulación, señalando un tamaño modesto de la transacción en relación con el float.

Las acciones provienen de opciones sobre acciones ejercidas el 28 de enero de 2021 y se ejecutarán en NASDAQ. Durante los últimos tres meses, el mismo fideicomiso ya ha vendido 19,287 acciones por ingresos brutos de $147,593.77 bajo un plan Rule 10b5-1. El declarante afirma no poseer información adversa material no divulgada.

Arteris, Inc. (AIP) � Form 144 제출. Viana Family Trust� 통해 식별� 계열 보유자가 6,909 보통�� Morgan Stanley Smith Barney� 통해 2025� 8� 8� 이후� 매각� 예정임을 신고했습니다. 제안� 매각� 추정 � 시장 가치는 $65,290.05이며, 주당 � $9.45� 평균 가격을 의미합니�. 이는 유통 주식 � 41,977,728� � � 0.02%� 해당하는 양으�, 유통 주식 대� 거래 규모가 작음� 나타냅니�.

해당 주식은 2021� 1� 28�� 행사� 스톡 옵션에서 비롯되었으며 NASDAQ에서 거래� 예정입니�. 지� 3개월 동안 동일� 신탁은 Rule 10b5-1 계획� 따라 이미 19,287�� 매도하여 � 수익 $147,593.77� 기록했습니다. 제출자는 공개되지 않은 중대� 부정적 정보가 없음� 확인했습니다.

Arteris, Inc. (AIP) � Dépôt du formulaire 144. Un détenteur affilié, identifié via le Viana Family Trust, a déposé un avis pour vendre 6 909 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney à partir du 8 août 2025. La valeur marchande estimée de la vente proposée est de 65 290,05 $, ce qui implique un prix moyen d'environ 9,45 $ par action. Le montant représente seulement environ 0,02 % des 41 977 728 actions en circulation, indiquant une taille de transaction modeste par rapport au flottant.

Les actions proviennent d'options sur actions exercées le 28 janvier 2021 et seront négociées sur le NASDAQ. Au cours des trois derniers mois, le même trust a déjà vendu 19 287 actions pour un produit brut de 147 593,77 $ dans le cadre d'un plan Rule 10b5-1. Le déposant affirme qu'aucune information négative importante non divulguée n'est présente.

Arteris, Inc. (AIP) � Einreichung des Formulars 144. Ein verbundener Inhaber, identifiziert über den Viana Family Trust, hat die Absicht gemeldet, 6.909 Stammaktien über Morgan Stanley Smith Barney ab dem 08. August 2025 zu verkaufen. Der geschätzte Gesamtmarktwert des geplanten Verkaufs beträgt 65.290,05 $, was einem durchschnittlichen Preis von etwa 9,45 $ pro Aktie entspricht. Die Menge macht nur etwa 0,02 % der 41.977.728 ausstehenden Aktien aus und signalisiert eine überschaubare Transaktionsgröße im Verhältnis zum Streubesitz.

Die Aktien stammen von am 28. Januar 2021 ausgeübten Aktienoptionen und werden an der NASDAQ gehandelt. In den letzten drei Monaten hat derselbe Trust bereits 19.287 Aktien für Bruttoerlöse von 147.593,77 $ im Rahmen eines Rule 10b5-1 Plans verkauft. Der Meldende bestätigt das Fehlen nicht offengelegter wesentlicher negativer Informationen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Southern William Bradley

(Last) (First) (Middle)
GMS INC.
115 PERIMETER CENTER PLACE, SUITE 600

(Street)
ATLANTA GA 30346

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GMS Inc. [ GMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 M 1,350 A $0(1) 1,776 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 08/01/2025 M 1,350 (2) (2) Common Stock 1,350 $0 0 D
Restricted Stock Units (3) 08/01/2025 A 1,141 (4) (4) Common Stock 1,141 $0 1,141 D
Explanation of Responses:
1. Restricted stock units vested and converted to shares of common stock on a one-for-one basis.
2. On August 1, 2024, the reporting person was granted 1,350 restricted stock units that vested on the first anniversary of the grant date.
3. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
4. Subject to the reporting person's continued service as a director of the issuer through the applicable vesting date, these restricted stock units are scheduled to vest on the first anniversary of the grant date and will be settled, with respect to vested restricted stock units, in shares of the issuer's common stock no later than 30 days after each applicable vesting date.
Remarks:
/s/ Craig D. Apolinsky, Attorney-in-Fact for William Bradley Southern 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Arteris (AIP) shares are insiders planning to sell?

The Form 144 covers 6,909 common shares slated for sale.

What is the estimated value of the proposed AIP share sale?

Aggregate market value is $65,290.05 based on the filing.

When will the Arteris shares be sold?

The approximate sale date listed is 08/05/2025 on NASDAQ.

How large is the sale relative to Arteris’s shares outstanding?

It represents roughly 0.02 % of 41,977,728 shares outstanding.

Has the insider sold AIP stock recently?

Yes, the same trust sold 19,287 shares for $147,593.77 on 06/05/2025.
Gms Inc

NYSE:GMS

GMS Rankings

GMS Latest News

GMS Latest SEC Filings

GMS Stock Data

4.17B
37.78M
0.7%
107.59%
3.18%
Building Products & Equipment
Wholesale-lumber & Other Construction Materials
United States
TUCKER